MARC details
| 000 -CABECERA |
|---|
| campo de control de longitud fija |
04706nam a22002895i 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| campo de control |
402943 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
|---|
| campo de control |
ES-MaUEC |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN |
|---|
| campo de control |
20240528105944.0 |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
cr nn 008mamaa |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
240123s2023 sz | o |||| 0|eng d |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
9783031389344 |
| 024 7# - IDENTIFICADOR DE OTROS ESTÁNDARES |
|---|
| Número estándar o código |
10.1007/978-3-031-38934-4 |
| Fuente del número o código |
doi |
| 040 ## - FUENTE DE LA CATALOGACIÓN |
|---|
| Centro catalogador/agencia de origen |
ES-MaUEC |
| Lengua de catalogación |
spa |
| Centro/agencia transcriptor |
ES-MaUEC |
| Centro/agencia modificador |
ES-MaUEC |
| 050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Número de clasificación |
RC1-1245 |
| Número de documento/Ítem |
2023 EB |
| 245 00 - MENCIÓN DE TÍTULO |
|---|
| Título |
Renal Denervation : |
| Resto del título |
Treatment and Device-Based Neuromodulation |
| Mención de responsabilidad, etc. |
edited by Richard R Heuser, Markus P Schlaich, Dagmara Hering, Stefan C Bertog |
| 250 ## - MENCIÓN DE EDICIÓN |
|---|
| Mención de edición |
2nd ed. 2023 |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
|---|
| Producción, publicación, distribución, fabricación y copyright |
Cham |
| Nombre del de productor, editor, distribuidor, fabricante |
Springer International Publishing |
| Fecha de producción, publicación, distribución, fabricación o copyright |
2023 |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extensión |
1 recurso en línea |
| 336 ## - TIPO DE CONTENIDO |
|---|
| Término de tipo de contenido |
texto |
| Código de tipo de contenido |
txt |
| Fuente |
rdacontent |
| 337 ## - TIPO DE MEDIO |
|---|
| Nombre/término del tipo de medio |
electrónico |
| Código del tipo de medio |
c |
| Fuente |
rdamedia |
| 338 ## - TIPO DE SOPORTE |
|---|
| Nombre/término del tipo de soporte |
recurso electrónico |
| Código del tipo de soporte |
cr |
| Fuente |
rdacarrier |
| 505 0# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Pathophysiology: The Target for Renal Denervation -- Physiological Rationale for Renal Denervation Therapy in Hypertension -- Preclinical Model and Histopathology Translational Medicine and Renal Denervation.-Appraisal of the Clinical Trial Data on Renal Denervation for the Management of Resistant Hypertension -- Catheter-Based Technology Alternatives for Renal Denervation: An Overview -- Vincristine Local Delivery for Renal Artery Denervation -- Renal Denervation: Potential Future Implications Beyond Resistant Hypertension -- Renal Denervation for Congestive Heart Failure -- The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease -- Diabetes and Metabolic Syndrome -- Obstructive Sleep Apnea -- Future of Renal Denervation Studies and Clinical Implementation -- Transcatheter Carotid Body Denervation (Cibiem): First-in-Man Results and Future Directions -- Mobius for Hypertension: Results to Date and Pivotal Trial.-Sensing Renal Nerve ActivityBefore, During and After Denervation: Autonomix -- Sensing Renal Nerve Activity Before, During and After Denervation: SyMap -- Patient Selection for Renal Denervation Therapy - From Mild Hypertension in the Young -- Is There an Unmet Need for Device Treatment for Moderate Hypertension? -- What are the FDA Parameters for Pivotal Successful Study Design for Device Approval for Hypertension Therapy? -- What are the FDA Parameters for Pivotal Successful Study Design for Device Approval for Hypertension Therapy? -- US Preventive Services Task Force Recommendation on ABPM Rationale/Potential Implications: How Much Reduction of Blood Pressure is Enough? -- Renal Denervation Cost Analysis and Consideration -- What Needs to Be Shown Before Renal Denervation Can Be Used in Clinical Practice? -- How to Screen Patients for Renal Denervation Trials? Why Is There US Apathy Toward ABPM: Low Reimbursement or Cognitive Dissonance? -- Renal Denervation: New Data From the Latest Feasibility Trials -- Evaluation ofthe Renal Nerve: Anatomy, Renal Nerve Distribution and Animal Models -- Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis -- Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: Radiance-Htn Solo -- Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have been Learned -- Chemical Renal Denervation with Alcohol: The Post-Market Study Data and The Target BP Program -- Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remain Unproven. . |
| 520 ## - SUMARIO, ETC. |
|---|
| Sumario, etc. |
This extensively revised edition examines renal pathophysiology and the rationale for renal denervation for the management of hypertension, as well as possible long-term benefits and risks of this therapy. Renal denervation is a minimally invasive, endovascular catheter-based procedure that makes use of radiofrequency ablation to treat resistant hypertension, with studies showing a high degree of effectiveness. The devices involved in the continued evolution of this therapy are discussed and the book incorporates analyses of the development of the technique while evaluating its cost effectiveness and future applications. Renal Denervation: A New Approach to Treatment of Resistant Hypertension describes the technique in detail, its advances and its pitfalls. While it has been estimated that 50% of Western civilization has hypertension and approximately 20% of patients have resistant hypertension, hypertension remains the leading cause of cardiovascular morbidity and mortality thus strengthening arguments to consider a wider range of potential solutions to manage these patients. |
| 988 ## - NOTA LOCAL 598 |
|---|
| Nota local 598 (boletines) |
Springer_Medicine_2023 |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
|---|
| Identificador Uniforme del Recurso |
https://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-38934-4 |
| Nota pública |
Acceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) |
|---|
| Fuente del sistema de clasificación o colocación |
Library of Congress Classification |
| Tipo de ítem Koha |
LIBRO-E NO PRÉSTAMO |